Results:
Keyword: Defense OR Acquisition OR Guidebook, OR Section OR 10.5.2.2

May 19, 2025

Project Announcement: Audit of the Defense Threat Reduction Agency’s Management of Grants (Project No. D2025-D000AU-0114.000)

The purpose of this memorandum is to notify you that we are initiating the subject audit. The objective of this audit is to determine whether the Defense Threat Reduction Agency (DTRA) effectively managed grants in accordance with terms and conditions.

May 16, 2025

Summary Report: Lessons Learned from DoD OIG Reports on Contract Oversight (Report No. DODIG-2025-096)

This report is one in a series of reports that summarizes key themes and lessons learned from our body of oversight work in several key areas. We offer these summaries to provide helpful and timely information relevant to DoD priorities.

May 15, 2025

Summary Report: Lessons Learned from DoD OIG Reports on Prepositioned Stocks (Report No. DODIG-2025-095)

This summary report is one in a series of reports that summarizes key themes and lessons learned from our body of oversight work in several key areas. We offer these summaries to provide helpful and timely information relevant to DoD priorities. To reduce deployment times and enable timely support during initial phases of an operation, the DoD maintains prepositioned war reserve materiel, comprising equipment and supplies in strategic locations around the globe.

May 13, 2025

Operation Atlantic Resolve (OAR)

We are pleased to present this Special Inspector General report to Congress on Operation Atlantic Resolve (OAR). This report discharges our quarterly reporting responsibilities pursuant to Section 1250B of the National Defense Authorization Act for 2024 and Lead IG reporting responsibilities under 5 U.S.C. 419.

May 5, 2025

Project Announcement: Evaluation of DoD and Military Department Efforts to Implement FY 2024 National Defense Authorization Act Requirements for Fentanyl (Project No. D2025-DEV0HD-0112.000)

The purpose of this memorandum is to notify you that we are initiating the subject evaluation. The objective of this evaluation is to determine the extent to which the DoD and Military Departments have implemented the FY 2024 National Defense Authorization Act requirements to (1) have naloxone readily available on all military installations and in operational environments, and (2) establish a standardized tracking system for naloxone distribution and personnel’s illegal use of fentanyl.

May 1, 2025

Audit of the Defense Health Agency’s Monitoring of TRICARE Payments (Report No. DODIG-2025-089)

The objective of this audit was to determine whether Defense Health Agency (DHA) officials effectively monitored TRICARE payments and took appropriate actions to limit incorrect and unreasonable payments.

April 30, 2025

Audit Of DoD Management of Hazardous Waste Disposals In Japan (Report No. DODIG-2025-088)

The objective of the audit was to determine whether the Military Services in Japan provided oversight over and processed hazardous waste disposals in accordance with DoD requirements.

April 29, 2025

Operation Inherent Resolve (OIR)

This quarterly report describes the activities of the U.S. Government in support of OIR as well as the work of the Department of Defense (DoD), the Department of State (State), and the U.S. Agency for International Development (USAID) to further the U.S. Government’s policy goals in Iraq and Syria during the period of January 1 through March 31, 2025. This report also discusses the planned, ongoing, and completed oversight work conducted by the Lead IG agencies—the DoD, State, and USAID OIGs—and our partner oversight agencies.

April 29, 2025

Audit of the DoD’s Compliance with the FY 2022 National Defense Authorization Act’s Requirements Concerning Zero Trust (Report No. DODIG-2025-090)

The objective of this audit was to determine whether the DoD complied with FY 2022 National Defense Authorization Act (NDAA) requirements to develop the DoD Zero Trust (ZT) strategy, principles, architecture, and implementation plans.

  • Office of Inspector General, United States Department of War, 4800 Mark Center Drive, Alexandria, VA 22350-1500